Y.-Q. Fu et al. / Tetrahedron: Asymmetry 17 (2006) 3351–3357
3355
cmꢁ1): 3286, 3200, 3061, 2978, 2942, 2923, 2871, 2746,
2705, 1662, 1600, 1546, 1509, 1455, 755; H NMR (D2O)
2.18–2.22 (m, 1H, CHHCH), 2.39 (s, 3H, CH3), 2.97–3.01
(m, 1H, CHHNH), 3.06–3.11 (m, 1H, CHHNH), 3.94–
3.98 (m, 1H, CHCO), 5.10 (s, 3H, 3NH), 7.06–7.10 (m,
1H, Ar–H), 7.15–7.21 (m, 2H, Ar–H), 7.20 (d,
J = 8.4 Hz, 2H, Ar0–H), 7.43 (d, J = 8.0 Hz, 1H, Ar–H),
7.56 (d, J = 8.4 Hz, 2H, Ar0–H); 13C NMR (CDCl3) d:
21.5, 26.0, 30.5, 47.0, 60.5, 123.3 (Ar–C), 125.9 (Ar–C),
127.1 (2Ar0–C), 127.3 (Ar–C), 127.5 (Ar–C), 128.5 (Ar–
C), 129.4 (2Ar0–C), 132.5 (Ar–C), 137.1 (Ar0–C), 143.4
(Ar0–C), 173.4 (C@O); HRMS; ESI; m/z: calcd for
C18H22N3O3S (M+H+) 360.1382, found: 360.1379.
1
d: 2.00 (m, 1H, CHCHHCH), 2.22 (m, 1H, CHCHHCH),
2.95–3.09 (m, 2H, NCH2), 4.14 (t, J = 8.4 Hz, 1H, CH),
4.45 (m, 1H, CH), 6.82–6.89 (m, 2H, Ar–H), 7.08
(m, 1H, Ar–H), 7.43 (dd, J = 8.0, 1.2 Hz, 1H, Ar–H); 13C
NMR (D2O) d: 38.6, 53.9, 59.3, 72.0, 116.6, 119.6, 124.0,
124.5, 127.4, 150.0, 174.6; HR MS; ESI; m/z: calcd for
C11H15N2O3 (M+H)+ 223.1083, found 223.1084.
4.2.3. (S)-N-(3,5-Di-tert-butyl-2-hydroxyphenyl)pyrrolidine-
2-carboxamide 1c. White solid, 504 mg, yield 79%; mp
20
217–218 ꢁC; ½aꢀD ¼ ꢁ36:8 (c 1.18, EtOH); IR (KBr,
4.3. General procedure for the preparation of aldol products
cmꢁ1): 3200, 2960, 2756, 1702, 1660, 1595, 1558, 1482,
1
1390, 1362, 1227, 874; H NMR (CDCl3) d: 1.22 (s, 9H,
4.3.1. General procedure for the aldol reaction of acetone
with aldehydes in neat acetone. To a stirred mixture of
0.5 mmol aldehyde and 1.0 mL acetone was added the cat-
alyst at the indicated temperature. The mixture was stirred
for the indicated time, then was purified by thin layer chro-
matography on silica gel (petroleum ether/ethyl acetate).
t-Bu), 1.35 (s, 9H, t-Bu), 1.76–1.93 (m, 3H, CH2CHHCH),
2.15 (m, 1H, CHHCH), 3.21–3.31 (m, 2H, NCH2), 5.04 (m,
1H, CH), 7.07 (d, J = 2.4 Hz, 1H, Ar–H), 7.17 (d, J =
2.4 Hz, 1H, Ar–H), 7.95 (s, 1H, NH), 9.44 (s, 1H, NHCO),
10.04 (s, 1H, OH); 13C NMR (CDCl3) d: 24.1, 29.8 (3CH3),
30.2, 31.5 (3CH3), 34.2, 35.2, 46.8, 60.3, 120.5, 122.5, 124.1,
138.3, 142.3, 146.7, 169.4; HR MS; ESI; m/z: calcd for
C19H31N2O2 (M+H)+ 319.2385, found 319.2381.
4.3.1.1. 4-Hydroxyl-4-(2-nitrophenyl)-butan-2-one. 1H
NMR (CDCl3) d: 2.24 (s, 3H), 2.74 (dd, J = 17.8, 9.4 Hz,
1H), 3.13 (dd, J = 17.8, 1.8 Hz, 1H), 3.89 (s, 1H), 5.68
(dd, J = 9.4, 1.8 Hz, 1H), 7.44 (t, J = 8.0 Hz, 1H), 7.67
(t, J = 8.0 Hz, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.96 (d,
J = 8.0 Hz 1H); HPLC: Chiralcel OD-H, UV 254,
i-PrOH/hexane = 15/85, flow rate 0.5 mL/min, (S)-isomer,
tR 17.8 min, (R)-isomer, tR 20.4 min.
4.2.4. (2S,4R)-4-Hydroxy-N-(3,5-di-tert-butyl-2-hydroxy-
phenyl)pyrrolidine-2-carboxamide 1d. White solid, 514 mg,
20
yield 77%; mp 78.4–80.1 ꢁC; ½aꢀD ¼ ꢁ16:2 (c 1.07, EtOH);
IR (KBr, cmꢁ1): 3386, 3199, 2955, 1685, 1659, 1596, 1560,
1519, 1481, 1456, 1362, 1225, 1032, 869; 1H NMR
(DMSO-d6) d: 1.24 (s, 9H, t-Bu), 1.36 (s, 9H, t-Bu), 1.78–
1.84 (m, 1H, CHCHHCH), 2.04–2.09 (m, 1H,
CHCHHCH), 2.84–2.92 (m, 2H, NCH2), 3.40 (s, 1H,
OH), 3.96 (t, J = 8.0 Hz, 1H, CH), 4.24 (m, 1H, CH), 4.74
(s, 1H, OH), 7.03 (d, J = 2.0 Hz, 1H, ArH), 7.41 (d,
J = 2.0 Hz, 1H, ArH), 8.83 (s, 1H, CONH), 10.13 (s, 1H,
ArOH); 13C NMR (DMSO-d6) d: 29.9 (3CH3), 31.5
(3CH3), 34.2, 35.0, 39.5, 55.2, 59.9, 71.6, 117.4, 119.5,
127.7, 138.5, 141.7, 144.5, 174.9; HR MS; ESI; m/z: calcd
for C19H31N2O3 (M+H)+ 335.2334, found 335.2324.
4.3.1.2. 4-Hydroxyl-4-(4-nitrophenyl)-butan-2-one. 1H
NMR (CDCl3) d: 2.24 (s, 3H), 2.87 (d, J = 6.0 Hz, 2H),
3.61 (s, 1H), 5.28 (t, 1H, J = 6.0 Hz), 7.55 (d, J = 8.8 Hz,
2H), 8.20 (dd, J = 8.8, 2.0 Hz, 2H); HPLC: Chiralcel
OD-H, UV 254, i-PrOH/hexane = 10/90; flow rate
0.5 mL/min, (R)-isomer, tR 37.8 min, (S)-isomer, tR
40.3 min.
4.3.1.3. 4-Hydroxyl-4-phenyl-butan-2-one. 1H NMR
(CDCl3) d: 2.13 (s, 3H), 2.74 (dd, J = 17.2, 3.2 Hz, 1H),
2.85 (dd, J = 17.2, 9.6 Hz, 1H), 3.63 (s, 1H), 5.10 (dd,
J = 9.6, 3.2 Hz, 1H), 7.24–7.32 (m, 5H); HPLC: Chiralpak
AD, i-PrOH/hexane = 5/95, flow rate 0.6 mL/min, (R)-iso-
mer, tR 23.4 min, (S)-isomer, tR 25.6 min.
4.2.5. (S)-N-(2-Hydroxynaphthalen-1-yl)pyrrolidine-2-car-
boxamide 1e. White solid, 370 mg; yield 74%; mp: 179–
20
181 ꢁC, ½aꢀD ¼ ꢁ28:3 (c 0.64, MeOH). IR (KBr disc)
cmꢁ1: 3344, 3294, 3268, 3208, 3064, 2983, 2884, 1677,
1627, 1575, 1505, 1280, 752; 1H NMR (DMSO-d6) d:
1.70–1.79 (m, 2H, CH2), 1.90–1.94 (m, 1H, CHH), 2.09–
2.14 (m, 1H, CHH), 2.98 (m, 2H, NCH2), 3.87 (dd,
J = 8.8, 5.6 Hz, 1H, NCH), 7.20 (d, J = 8.8 Hz, 1H, Ar–
H), 7.31 (t, J = 7.6 Hz, 1H, Ar–H), 7.45 (t, J = 7.6 Hz,
1H, Ar–H), 7.62 (d, J = 8.4 Hz, 1H, Ar–H), 7.72
(d, J = 8.8 Hz, 1H, Ar–H), 7.82 (d, J = 8.0 Hz, 1H, Ar–
H), 9.77 (br, 2H, NHCO, OH); 13C NMR (DMSO-d6)
d: 26.2, 30.9, 47.0, 60.8, 116.8, 119.1, 121.9, 123.1, 126.4,
127.7, 128.1, 128.3, 130.9, 149.7, 174.9; HRMS; ESI; m/z:
4.3.2. General procedure for the aldol reaction of cyclo-
hexanone with aldehydes
4.3.2.1. Reaction in neat ketone. Catalyst (0.05 mmol)
was added to a solution of 0.5 mmol of aldehyde in
1.0 mL cyclohexanone. After being stirred for the indicated
time, the mixture was treated with saturated ammonium
chloride solution and extracted with ethyl acetate. The
organic layer was dried over MgSO4, filtered, and concen-
trated to give pure aldol product after thin layer
chromatographic purification on silica gel (petroleum
ether/ethyl acetate).
calcd for C15H16N2Oþ; M+H+Å; 257.1290, found 257.1291.
2
4.2.6. (S)-N-(2-(4-Methylphenylsulfonamido)phenyl)pyrrol-
idine-2-carboxamide 1f. Yellow-white powder: mp 62.7–
4.3.2.2. Reaction in water. Aldehyde (0.33 mmol) was
added to the mixture of 0.4 mL cyclohexanone, 1.0 mL
water, and 0.067 mmol of catalyst. After being stirred at
room temperature for the indicated time, the mixture was
treated the same as that of the step in neat ketone.
20
64.4 ꢁC; ½aꢀD ¼ ꢁ60:8 (c 0.88, EtOH); IR (KBr, cmꢁ1):
3376, 3243, 3064, 2971, 2875, 1672, 1597, 1525, 1453,
1
1333, 1161, 1092, 815, 760, 661, 565; H NMR (CDCl3)
d: 1.76–1.81 (m, 2H, CH2), 1.95–1.98 (m, 1H, CHHCH),